Condition
Life Threatening Diseases
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06915883Not ApplicableCompleted
Experiential and Relaxation Virtual Reality as a Tool for Easing Anxiety in Seriously Ill Children
NCT03078387CompletedPrimary
The Extreme Significance of Bilateral Embolic Retinal Phenomena That Can be Life Saving
NCT00154388Phase 2CompletedPrimary
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Showing all 3 trials